Search Results - "MOOSIG, Frank"

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis by Wechsler, Michael E, Akuthota, Praveen, Jayne, David, Khoury, Paneez, Klion, Amy, Langford, Carol A, Merkel, Peter A, Moosig, Frank, Specks, Ulrich, Cid, Maria C, Luqmani, Raashid, Brown, Judith, Mallett, Stephen, Philipson, Richard, Yancey, Steve W, Steinfeld, Jonathan, Weller, Peter F, Gleich, Gerald J

“…Among participants with eosinophilic granulomatosis with polyangiitis, 32% had remission at weeks 36 and 48 when treated with mepolizumab, an…”
Get full text

Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays by Damoiseaux, Jan, Csernok, Elena, Rasmussen, Niels, Moosig, Frank, van Paassen, Pieter, Baslund, Bo, Vermeersch, Pieter, Blockmans, Daniel, Cohen Tervaert, Jan-Willem, Bossuyt, Xavier

“…This multicentre study was performed to evaluate the diagnostic accuracy of a wide spectrum of novel technologies nowadays available for detection of…”
Get more information

Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status by Lyons, Paul A, Peters, James E, Alberici, Federico, Liley, James, Coulson, Richard M. R., Astle, William, Baldini, Chiara, Bonatti, Francesco, Cid, Maria C, Elding, Heather, Emmi, Giacomo, Epplen, Jörg, Guillevin, Loïc, Jayne, David R. W., Jiang, Tao, Gunnarsson, Iva, Lamprecht, Peter, Leslie, Stephen, Little, Mark A., Martorana, Davide, Moosig, Frank, Neumann, Thomas, Ohlsson, Sophie, Quickert, Stefanie, Ramirez, Giuseppe A., Rewerska, Barbara, Schett, Georg, Sinico, Renato A., Szczeklik, Wojciech, Tesar, Vladimir, Vukcevic, Damjan, Terrier, Benjamin, Watts, Richard A, Vaglio, Augusto, Holle, Julia U, Wallace, Chris, Smith, Kenneth G. C.

“…Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare inflammatory disease of unknown cause. 30% of patients have anti-neutrophil cytoplasmic…”
Get full text

Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome by Moosig, Frank, Gross, Wolfgang Ludwig, Herrmann, Kristina, Bremer, Jan Phillip, Hellmich, Bernhard

Get full text

A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility by Carmona, F. David, Mackie, Sarah L., Martín, Jose-Ezequiel, Taylor, John C., Vaglio, Augusto, Eyre, Stephen, Bossini-Castillo, Lara, Castañeda, Santos, Cid, Maria C., Hernández-Rodríguez, José, Prieto-González, Sergio, Solans, Roser, Ramentol-Sintas, Marc, González-Escribano, M. Francisca, Ortiz-Fernández, Lourdes, Morado, Inmaculada C., Narváez, Javier, Miranda-Filloy, José A., Martínez-Berriochoa, Agustín, Unzurrunzaga, Ainhoa, Hidalgo-Conde, Ana, Madroñero-Vuelta, Ana B., Fernández-Nebro, Antonio, Ordóñez-Cañizares, M. Carmen, Escalante, Begoña, Marí-Alfonso, Begoña, Sopeña, Bernardo, Magro, César, Raya, Enrique, Grau, Elena, Román, José A., de Miguel, Eugenio, López-Longo, F. Javier, Martínez, Lina, Gómez-Vaquero, Carmen, Rodríguez-Rodríguez, Luis, Díaz-López, J. Bernardino, Caminal-Montero, Luis, Monfort, Jordi, Tío, Laura, Alegre-Sancho, Juan J., Sáez-Comet, Luis, Pérez-Conesa, Mercedes, Corbera-Bellalta, Marc, Fernández-Contreras, M. Encarnación, Sanchez-Pernaute, Olga, Blanco, Ricardo, Ortego-Centeno, Norberto, Ríos-Fernández, Raquel, Callejas, José L., Fanlo-Mateo, Patricia, Martínez-Taboada, Víctor M., Lunardi, Claudio, Cimmino, Marco A., Santilli, Daniele, Ramirez, Giuseppe A., Soriano, Alessandra, Muratore, Francesco, Pazzola, Giulia, Addimanda, Olga, Wijmenga, Cisca, Witte, Torsten, Schirmer, Jan H., Moosig, Frank, Franke, Andre, Molberg, Øyvind, Diamantopoulos, Andreas P., Carette, Simon, Cuthbertson, David, Hoffman, Gary S., Khalidi, Nader A., Koening, Curry L., Langford, Carol A., McAlear, Carol A., Moreland, Larry, Monach, Paul A., Pagnoux, Christian, Seo, Philip, Spiera, Robert, Sreih, Antoine G., Ytterberg, Steven R., Gregersen, Peter K., Pease, Colin T., Gough, Andrew, Green, Michael, Hordon, Lesley, Jarrett, Stephen, Watts, Richard, Levy, Sarah, Patel, Yusuf, Kamath, Sanjeet, Dasgupta, Bhaskar, Worthington, Jane, Koeleman, Bobby P.C., de Bakker, Paul I.W., Barrett, Jennifer H., Merkel, Peter A., González-Gay, Miguel A., Morgan, Ann W., Martín, Javier

“…We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic immune-mediated vasculitis. A case-control cohort, comprising 1,651 case…”
Get full text

Pain in oxaliplatin-induced neuropathy – Sensitisation in the peripheral and central nociceptive system by Binder, Andreas, Stengel, Maike, Maag, Rainer, Wasner, Gunnar, Schoch, Robert, Moosig, Frank, Schommer, Bernhard, Baron, Ralf

“…Abstract Background This study aimed to determine the somatosensory characteristics and pain types in patients with acute oxaliplatin-induced neuropathy and to…”
Get full text

COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey by Kernder, Anna, Filla, Tim, de Groot, Kirsten, Hellmich, Bernhard, Holle, Julia, Lamprecht, Peter, Moosig, Frank, Ruffer, Nikolas, Specker, Christof, Vordenbäumen, Stefan, Schneider, Matthias, Chehab, Gamal

“…To analyze the impact of the COVID-19 pandemic on medical care and vaccination acceptance of vasculitis patients in Germany. A web-based national survey was…”
Get full text

Presence of Antibodies Binding to Negative Elongation Factor E in Sarcoidosis by Baerlecken, Niklas, Pursche, Nils, Witte, Torsten, Kniesch, Katja, Höpfner, Marius, Ernst, Diana, Moosig, Frank, Seeliger, Benjamin, Prasse, Antje

“…Sarcoidosis is characterized by multiorgan involvement and granulomatous inflammation. Its origin is unknown and the potential role of autoimmunity has not…”
Get full text

Getting rid of MPO-ANCA: a matter of disease subtype by Bremer, Jan P, Csernok, Elena, Holle, Julia, Gross, Wolfgang L, Moosig, Frank

Get full text

Current and emerging techniques for ANCA detection in vasculitis by Csernok, Elena, Moosig, Frank

“…Key Points Screening for antineutrophil cytoplasmic antibodies (ANCAs) specific for proteinase 3 (PR3) and myeloperoxidase (MPO) remains a basic tool in the…”
Get full text

Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic by Schulze-Koops, Hendrik, Specker, Christof, Iking-Konert, Christof, Holle, Julia, Moosig, Frank, Krueger, Klaus

Get more information

Eosinophilic granulomatosis with polyangiitis : Update on classification and management by Hellmich, Bernhard, Holle, Julia, Moosig, Frank

“…Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare chronic inflammatory systemic disease that occurs in patients with bronchial asthma and is…”
Get full text

Churg–Strauss syndrome: update on pathophysiology and treatment by Vaglio, Augusto, Moosig, Frank, Zwerina, Jochen

“…PURPOSE OF REVIEWChurg–Strauss syndrome (CSS) has a clear clinical phenotype but its pathogenesis is not fully elucidated. Recent studies have focused on its…”
Get full text

Update on treatment of ANCA-associated vasculitis by Holle, Julia U, Moosig, Frank

“…This article summarizes the current guidelines and recommendations published by the European Alliance of Associations for Rheumatology (EULAR), the Kidney…”
Get full text

Joint pain - a rheumatic disease? by Moosig, Frank, Holle, Julia U

“…Pain in the musculoskeletal system and therefore joint pain is one of the most common reasons for consulting a general practitioner (GP). Inflammatory…”
Get more information

2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis by Ponte, Cristina, Grayson, Peter C, Robson, Joanna C, Suppiah, Ravi, Gribbons, Katherine Bates, Judge, Andrew, Craven, Anthea, Khalid, Sara, Hutchings, Andrew, Watts, Richard A, Merkel, Peter A, Luqmani, Raashid A

“…To develop and validate updated classification criteria for giant cell arteritis (GCA). Patients with vasculitis or comparator diseases were recruited into an…”
Get more information

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): evolutions in classification, etiopathogenesis, assessment and management by Mahr, Alfred, Moosig, Frank, Neumann, Thomas, Szczeklik, Wojciech, Taillé, Camille, Vaglio, Augusto, Zwerina, Jochen

“…PURPOSE OF REVIEWEosinophilic granulomatosis with polyangiitis (EGPA) (Churg–Strauss syndrome) is a peculiar hybrid condition of a systemic antineutrophil…”
Get full text

Das Böse ist immer und überall by Holle, Julia, Moosig, Frank

Get full text

L6. Eosinophilic granulomatosis with polyangiitis: Future therapies by Moosig, Frank

Get full text

Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis by Steinfeld, Jonathan, Bradford, Eric S., Brown, Judith, Mallett, Stephen, Yancey, Steven W., Akuthota, Praveen, Cid, Maria C., Gleich, Gerald J., Jayne, David, Khoury, Paneez, Langford, Carol A., Merkel, Peter A., Moosig, Frank, Specks, Ulrich, Weller, Peter F., Wechsler, Michael E.

“…In a recent phase III trial (NCT02020889) 53% of mepolizumab-treated versus 19% of placebo-treated patients with eosinophilic granulomatosis with polyangiitis…”
Get full text